Sandeep Nayak
Physician-Scientist
Data updated
Research Footprint
Sandeep Nayak appears in 28 tracked papers (2020–2026) and 2 clinical trials, most studied alongside Psilocybin, DMT and LSD, across Depressive Disorders, Anxiety Disorders and Substance Use Disorders (SUD).
Most-cited paper: Psychedelics, placebo effects, and set and setting: insights from common factors theory of psychotherapy (145 citations).
Frequent co-authors: David Yaden, Roland Griffiths and Albert Garcia-Romeu.
Background & Research
Sandeep Nayak, MD, is a physician‑scientist affiliated with Johns Hopkins whose research focuses on the clinical, cognitive and safety consequences of classic psychedelics in both naturalistic and research settings. He has led and co‑authored prospective longitudinal work examining how psilocybin experiences alter mind perception and related belief systems, and has contributed to multiple analyses that probe drug–drug interactions and adverse events (for example, attenuation of psilocybin effects associated with SSRI/SNRI exposure and seizure risk signals when classic psychedelics are co‑administered with lithium). His publications also include comparative investigations of psychedelic and non‑ordinary experiences (such as near‑death experiences) and analyses of single transformative psychedelic experiences and their effects on attribution of consciousness to living and non‑living entities.
Beyond substantive clinical studies, Nayak has emphasised methodological rigour in psychedelic science — advocating for improved adverse‑event surveillance, reducing reporting bias and applying Bayesian approaches to trial design and analysis. He collaborates with neuroimaging groups and multidisciplinary teams to link phenomenology, safety, and neural measures, aiming to translate observational and experimental findings into safer, better‑characterised interventions for psychiatric care.
Key Impact
Known for empirical and methodological work on psychedelic-induced belief change, naturalistic psilocybin outcomes, and safety signals from drug co‑administration that inform clinical practice and trial design.
Collaboration Network
34 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Sandeep Nayak is associated with.
Johns Hopkins University
academicThe Centre for Psychedelic and Consciousness Research focuses on how psychedelics affect behavior, cognition, brain function, and biological health markers. They have been at the forefront of demonstrating the safety and efficacy of psychedelics for mental disorders, expanding their focus into psilocybin research across multiple mental health conditions, including smoking cessation, major depressive disorder, and cancer-related anxiety.
View stakeholder →Johns Hopkins Center for Psychedelic and Consciousness Research
A research center within Johns Hopkins University (School of Medicine) that conducts scientific studies on psychedelic compounds, their effects on brain function and consciousness, and their therapeutic potential for mental health conditions.
View stakeholder →